EQS-News: Cherry SE and CFO Dr. Mathias Dähn reach agreement on early separation as of July 31, 2024

EQS-News: Cherry SE / Key word(s): Personnel
Cherry SE and CFO Dr. Mathias Dähn reach agreement on early separation as of July 31, 2024

19.07.2024 / 12:21 CET/CEST
The issuer is solely responsible for the content of this announcement.

Cherry SE and CFO Dr. Mathias Dähn reach agreement on early separation as of July 31, 2024

Munich, July 19, 2024 - Cherry SE, an international manufacturer of computer input devices such as keyboards, mice and headsets for applications in the areas of gaming e-sports, office hybrid workplaces as well as industry and healthcare, today announced the early separation from CFO, Dr. Mathias Dähn, as of July 31, 2024.

Dr. Mathias Dähn was appointed Chief Financial Officer by the Supervisory Board with effect from April 15, 2023. The decision to terminate the mandate early was made by mutual agreement.

Marcel Stolk, Chairman of the Supervisory Board of Cherry SE: "On behalf of the Supervisory Board of Cherry SE, we would like to thank Dr. Mathias Dähn for his commitment to our company, especially during our restructuring in 2023. We wish him all the best for his future private and professional plans."

Effective from August 1, 2024, responsibility for Global Finance IT will be permanently transferred to Volker Christ, who has been serving as Interim CFO. In his ongoing role, Mr. Christ will be Executive Vice President Global Finance IT with a direct reporting line to CEO Oliver Kaltner.

The Supervisory Board of Cherry SE also informs that this will not result in a direct replacement on the Executive Board of Cherry SE. Rather, the Executive Board will be represented by Oliver Kaltner (CEO) and Dr. Udo Streller (COO).

About Cherry
Cherry SE [ISIN: DE000A3CRRN9] is a globally operating manufacturer of high-end mechanical keyboard switches and computer input devices such as keyboards, mice, and headsets for applications in the worlds of gaming, e-sports, office and hybrid workplaces, industry, and healthcare. Since it was founded in 1953, Cherry has been synonymous with innovative, high-quality products developed specifically to meet the various needs of its customers.
Cherry has its operational headquarters in Auerbach in Germany's Upper Palatinate region and employs in production facilities in Auerbach, Zhuhai (China), and Vienna (Austria) as well as in various sales offices in Auerbach (Germany), Pegnitz (Germany) Munich (Germany), Landskrona (Sweden), Paris (France), Kenosha (USA), Taipei (Taiwan), and Hong Kong (China).

For more information: https://ir.cherry.de

Contact
Cherry SE
Nicole Schillinger
Investor Relations
P: Rosental 7, c/o Mindspace, 80331 München
T: +49 (0) 9643 2061 848
E: nicole.schillinger@cherry.de
 

19.07.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English Company: Cherry SE Rosental 7, c/o Mindspace 80331 Munich Germany ISIN: DE000A3CRRN9 WKN: A3CRRN Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1950255
  End of News EQS News Service

1950255  19.07.2024 CET/CEST